Titre : Évidement ganglionnaire cervical

Évidement ganglionnaire cervical : Questions médicales fréquentes

Termes MeSH sélectionnés :

Early Detection of Cancer
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Évidement ganglionnaire cervical : Questions médicales les plus fréquentes", "headline": "Évidement ganglionnaire cervical : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Évidement ganglionnaire cervical : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-27", "dateModified": "2025-03-22", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Évidement ganglionnaire cervical" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Procédures de chirurgie oto-rhino-laryngologique", "url": "https://questionsmedicales.fr/mesh/D013517", "about": { "@type": "MedicalCondition", "name": "Procédures de chirurgie oto-rhino-laryngologique", "code": { "@type": "MedicalCode", "code": "D013517", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E04.580" } } }, "about": { "@type": "MedicalCondition", "name": "Évidement ganglionnaire cervical", "alternateName": "Neck Dissection", "code": { "@type": "MedicalCode", "code": "D037981", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Umamaheswar Duvvuri", "url": "https://questionsmedicales.fr/author/Umamaheswar%20Duvvuri", "affiliation": { "@type": "Organization", "name": "Department of Otolaryngology, University of Pittsburgh, 203 Lothrop Street, Suite 500, Pittsburgh, PA 15213, USA; Department of Veterans Affairs, Pittsburgh Health System, University Drive C, Pittsburgh, PA 15240, USA. Electronic address: duvvuriu@upmc.edu." } }, { "@type": "Person", "name": "Joe Iwanaga", "url": "https://questionsmedicales.fr/author/Joe%20Iwanaga", "affiliation": { "@type": "Organization", "name": "Clinical Anatomy Research Association in Oral and Maxillofacial Surgery, Fukuoka, Japan." } }, { "@type": "Person", "name": "R Shane Tubbs", "url": "https://questionsmedicales.fr/author/R%20Shane%20Tubbs", "affiliation": { "@type": "Organization", "name": "Clinical Anatomy Research Association in Oral and Maxillofacial Surgery, Fukuoka, Japan." } }, { "@type": "Person", "name": "Aman M Patel", "url": "https://questionsmedicales.fr/author/Aman%20M%20Patel", "affiliation": { "@type": "Organization", "name": "Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA." } }, { "@type": "Person", "name": "Afash Haleem", "url": "https://questionsmedicales.fr/author/Afash%20Haleem", "affiliation": { "@type": "Organization", "name": "Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study.", "datePublished": "2023-06-19", "url": "https://questionsmedicales.fr/article/37343766", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.modpat.2023.100241" } }, { "@type": "ScholarlyArticle", "name": "Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer - Controversies and Standards in Healthcare.", "datePublished": "2023-05-23", "url": "https://questionsmedicales.fr/article/37614683", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/a-2073-1887" } }, { "@type": "ScholarlyArticle", "name": "Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial.", "datePublished": "2023-04-03", "url": "https://questionsmedicales.fr/article/37022687", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2023.5822" } }, { "@type": "ScholarlyArticle", "name": "Circulating tumor DNA in molecular assessment feasibly predicts early progression of pancreatic cancer that cannot be identified via initial imaging.", "datePublished": "2023-03-23", "url": "https://questionsmedicales.fr/article/36959222", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-31051-7" } }, { "@type": "ScholarlyArticle", "name": "Hypofractionated whole breast irradiation in association with hypofractionated or normofractionated boost to the tumor bed in early breast cancer: tolerance and efficacy analysis.", "datePublished": "2023-03-22", "url": "https://questionsmedicales.fr/article/36947361", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12094-023-03124-6" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Procédures de chirurgie opératoire", "item": "https://questionsmedicales.fr/mesh/D013514" }, { "@type": "ListItem", "position": 3, "name": "Procédures de chirurgie oto-rhino-laryngologique", "item": "https://questionsmedicales.fr/mesh/D013517" }, { "@type": "ListItem", "position": 4, "name": "Évidement ganglionnaire cervical", "item": "https://questionsmedicales.fr/mesh/D037981" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Évidement ganglionnaire cervical - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Évidement ganglionnaire cervical", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Évidement ganglionnaire cervical", "description": "Comment diagnostiquer un cancer nécessitant un évidement ganglionnaire ?\nQuels tests sont utilisés pour évaluer les ganglions lymphatiques ?\nQuels signes cliniques indiquent un besoin d'évidement ?\nQuelle est l'importance de l'examen histologique ?\nQuand un scanner est-il recommandé ?", "url": "https://questionsmedicales.fr/mesh/D037981?mesh_terms=Early+Detection+of+Cancer&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Évidement ganglionnaire cervical", "description": "Quels symptômes peuvent indiquer un cancer du cou ?\nComment se manifeste une infection des ganglions ?\nQuels signes d'alerte nécessitent une consultation rapide ?\nLes douleurs au cou sont-elles toujours liées à un cancer ?\nQuels symptômes post-opératoires sont normaux ?", "url": "https://questionsmedicales.fr/mesh/D037981?mesh_terms=Early+Detection+of+Cancer&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Évidement ganglionnaire cervical", "description": "Comment prévenir le cancer du cou ?\nLes vaccinations peuvent-elles aider ?\nQuel rôle joue le dépistage précoce ?\nComment réduire le risque d'infections ?\nLes examens réguliers sont-ils importants ?", "url": "https://questionsmedicales.fr/mesh/D037981?mesh_terms=Early+Detection+of+Cancer&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Évidement ganglionnaire cervical", "description": "Quel est le but de l'évidement ganglionnaire ?\nQuels types d'évidement existent ?\nQuelles sont les alternatives à l'évidement ?\nComment se déroule l'intervention chirurgicale ?\nQuels soins sont nécessaires après l'évidement ?", "url": "https://questionsmedicales.fr/mesh/D037981?mesh_terms=Early+Detection+of+Cancer&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Évidement ganglionnaire cervical", "description": "Quelles sont les complications possibles après l'évidement ?\nComment gérer une infection post-opératoire ?\nQuels signes indiquent une complication grave ?\nLes cicatrices sont-elles inévitables ?\nComment prévenir les complications ?", "url": "https://questionsmedicales.fr/mesh/D037981?mesh_terms=Early+Detection+of+Cancer&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Évidement ganglionnaire cervical", "description": "Quels sont les principaux facteurs de risque du cancer du cou ?\nLe sexe influence-t-il le risque de cancer ?\nL'âge joue-t-il un rôle dans le risque ?\nUne mauvaise hygiène buccale est-elle un facteur de risque ?\nLes antécédents familiaux influencent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D037981?mesh_terms=Early+Detection+of+Cancer&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un cancer nécessitant un évidement ganglionnaire ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic est établi par biopsie, imageries (IRM, TDM) et examens cliniques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les ganglions lymphatiques ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les échographies, TDM et IRM sont couramment utilisés pour évaluer les ganglions." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent un besoin d'évidement ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des ganglions enflés, durs ou douloureux peuvent indiquer un besoin d'évidement." } }, { "@type": "Question", "name": "Quelle est l'importance de l'examen histologique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'examen histologique permet de confirmer la présence de cellules cancéreuses dans les ganglions." } }, { "@type": "Question", "name": "Quand un scanner est-il recommandé ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Un scanner est recommandé pour évaluer l'extension du cancer et planifier l'intervention." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un cancer du cou ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des ganglions enflés, douleur au cou, difficulté à avaler." } }, { "@type": "Question", "name": "Comment se manifeste une infection des ganglions ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Une infection peut provoquer douleur, rougeur, chaleur et gonflement des ganglions." } }, { "@type": "Question", "name": "Quels signes d'alerte nécessitent une consultation rapide ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des ganglions persistants, une perte de poids inexpliquée ou des sueurs nocturnes sont alarmants." } }, { "@type": "Question", "name": "Les douleurs au cou sont-elles toujours liées à un cancer ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Non, les douleurs au cou peuvent être causées par diverses conditions, pas seulement le cancer." } }, { "@type": "Question", "name": "Quels symptômes post-opératoires sont normaux ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Un léger gonflement et des douleurs au site chirurgical sont normaux après l'intervention." } }, { "@type": "Question", "name": "Comment prévenir le cancer du cou ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabac, limiter l'alcool et adopter une alimentation saine peuvent aider." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles aider ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la vaccination contre le HPV peut réduire le risque de cancers oropharyngés." } }, { "@type": "Question", "name": "Quel rôle joue le dépistage précoce ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Le dépistage précoce permet de détecter le cancer à un stade plus traitable." } }, { "@type": "Question", "name": "Comment réduire le risque d'infections ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène buccale et éviter les contacts avec des personnes malades aide." } }, { "@type": "Question", "name": "Les examens réguliers sont-ils importants ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des examens réguliers permettent de détecter des anomalies précocement." } }, { "@type": "Question", "name": "Quel est le but de l'évidement ganglionnaire ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "L'évidement vise à retirer les ganglions lymphatiques affectés pour contrôler le cancer." } }, { "@type": "Question", "name": "Quels types d'évidement existent ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il existe l'évidement sélectif, radical et modéré, selon l'étendue de la maladie." } }, { "@type": "Question", "name": "Quelles sont les alternatives à l'évidement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les alternatives incluent la radiothérapie et la chimiothérapie, selon le cas." } }, { "@type": "Question", "name": "Comment se déroule l'intervention chirurgicale ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "L'intervention se fait sous anesthésie générale, avec une incision pour retirer les ganglions." } }, { "@type": "Question", "name": "Quels soins sont nécessaires après l'évidement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des soins de plaie, gestion de la douleur et suivi médical sont nécessaires après l'opération." } }, { "@type": "Question", "name": "Quelles sont les complications possibles après l'évidement ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent infections, saignements, et lésions nerveuses." } }, { "@type": "Question", "name": "Comment gérer une infection post-opératoire ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Une infection peut nécessiter des antibiotiques et un suivi médical régulier." } }, { "@type": "Question", "name": "Quels signes indiquent une complication grave ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs intenses, fièvre élevée ou écoulement anormal doivent alerter." } }, { "@type": "Question", "name": "Les cicatrices sont-elles inévitables ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des cicatrices sont inévitables, mais leur apparence peut s'améliorer avec le temps." } }, { "@type": "Question", "name": "Comment prévenir les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Suivre les instructions post-opératoires et signaler tout symptôme anormal aide à prévenir." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque du cancer du cou ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent le tabagisme, l'alcool, et l'exposition au HPV." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque de cancer ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains cancers du cou sont plus fréquents chez les hommes que chez les femmes." } }, { "@type": "Question", "name": "L'âge joue-t-il un rôle dans le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de cancer du cou augmente avec l'âge, surtout après 50 ans." } }, { "@type": "Question", "name": "Une mauvaise hygiène buccale est-elle un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une mauvaise hygiène buccale peut augmenter le risque de cancers oropharyngés." } }, { "@type": "Question", "name": "Les antécédents familiaux influencent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de cancer augmentent le risque de développer un cancer." } } ] } ] }

Sources (10000 au total)

Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial.

Trastuzumab has been the standard of care for the treatment of patients with ERBB2-positive breast cancer; however, cardiac events have been reported. This long-term follow-up study provides clinical ... To compare cardiac safety and efficacy between SB3 and TRZ for patients with ERBB2-positive early or locally advanced breast cancer after up to 6 years of follow-up.... This prespecified secondary analysis of a randomized clinical trial, conducted from April 2016 to January 2021, included patients with ERBB2-positive early or locally advanced breast cancer from a mul... In the original trial, patients were randomized to either SB3 or TRZ with concomitant neoadjuvant chemotherapy for 8 cycles (4 cycles of docetaxel followed by 4 cycles of fluorouracil, epirubicin, and... The primary outcomes were the incidence of symptomatic congestive heart failure and asymptomatic, significant decrease in left ventricular ejection fraction (LVEF). The secondary outcomes were event-f... A total of 538 female patients were included (median age, 51 years [range, 22-65 years]). Baseline characteristics were comparable between the SB3 and TRZ groups. Cardiac safety was monitored for 367 ... In this secondary analysis of a randomized clinical trial, SB3 demonstrated cardiac safety and survival comparable to those of TRZ after up to 6 years of follow-up in patients with ERBB2-positive earl... ClinicalTrials.gov Identifier: NCT02771795....

Circulating tumor DNA in molecular assessment feasibly predicts early progression of pancreatic cancer that cannot be identified via initial imaging.

Molecular assessment using circulating tumor DNA (ctDNA) has not been well-defined. We recruited 61 pancreatic cancer (PC) patients who underwent initial computed tomography (CT) imaging study during ...

Hypofractionated whole breast irradiation in association with hypofractionated or normofractionated boost to the tumor bed in early breast cancer: tolerance and efficacy analysis.

The boost to the tumor bed improves local control in breast cancer and it is an important part of the breast conserving therapy. However, information about the use of a hypofractionated boost is spars... A total of 96 women with early breast cancer undergoing breast-conserving surgery and hypofractionated whole breast irradiation (WBI) were retrospectively analyzed divided into hypofractionated boost ... The median follow-up was 49.5 months (26-67). Median age was 57 years (36-82). Sixty-six patients (68.7%) were younger than 60 years at the time of boost and 30 (31.2%) were older than 60 years who re... Hypofractionated WBI associated with HB treatment is a viable option in the management of conservative breast therapy given the good tolerance and similar local control....

Analysis of risk factors for lymph node metastasis and prognosis study in patients with early gastric cancer: A SEER data-based study.

Lymph node status is an important factor in determining the prognosis of patients with early gastric cancer (EGC) and preoperative diagnosis of lymph node metastasis (LNM) has some limitations. This s... Clinicopathological data of EGC patients was collected from the public Surveillance, Epidemiology, and End Results (SEER) database. Univariate and multivariate logistic regression was used to identify... A total of 3993 EGC patients were randomly allocated to a training cohort (n=2797) and a validation cohort (n=1196). An external cohort of 106 patients from the Second Hospital of Lanzhou University w... In this study, we identified risk factors and independent prognostic factors for the development of LNM in EGC patients, and developed a relatively accurate model to predict the development of LNM in ...

Comparison of the effects of endoscopic submucosal dissection and laparoscopic distal radical surgery on the rehabilitation and quality of life of patients with early gastric cancer.

This study was designed to compare the effects of endoscopic submucosal dissection (ESD) and laparoscopic distal radical surgery (LDRS) on patient rehabilitation and quality of life (QoL) in patients ... The clinical data of 52 patients with early GC admitted to Wuhan Union Hospital from January 2018 to December 2020 were retrospectively analyzed. Among them, 32 patients who underwent LDRS were assign... The laparoscopic group showed a significantly lower complete resection rate than the endoscopic group (P=0.030). The endoscopic group experienced notably less intraoperative blood loss and operation t... With significantly better efficacy than that of LDRS, ESD is beneficial to postoperative rehabilitation and can improve the QoL of patients, and both schemes cause no significant effect on the recurre...

Establishment and validation of a multigene model to predict the risk of relapse in hormone receptor-positive early-stage Chinese breast cancer patients.

Breast cancer patients who are positive for hormone receptor typically exhibit a favorable prognosis. It is controversial whether chemotherapy is necessary for them after surgery. Our study aimed to e... In this study, differentially expressed genes (DEGs) were identified between relapse and nonrelapse breast cancer groups based on RNA sequencing. Gene set enrichment analysis (GSEA) was performed to i... A total of 234 out of 487 patients were enrolled in this study, and 1588 DEGs were identified between the relapse and nonrelapse groups. GSEA results showed that immune-related pathways were enriched ... A multigene model was established from RNA-sequencing data to direct risk classification and predict relapse of hormone receptor-positive breast cancer in Chinese patients. Utilization of the model co...

Impact of age on indication for chemotherapy in early breast cancer patients: results from 104 German institutions from 2008 to 2017.

Today, the decision to treat patients with chemotherapy for early breast cancer (EBC) is made based on the patient's individual risk stratification and tumor biology. In cases with chemotherapy indica... The study separately analyzed chemotherapy use among six age cohorts of EBC patients who had been treated at 104 German breast units between January 2008 and December 2017.... In total, 124,084 patients were included, 46,279 (37.3%) of whom had received chemotherapy. For 44,765 of these cases, detailed information on treatment was available. Within this cohort, chemotherapy... The data from the nationwide German cohort reveal relevant age-dependent discrepancies concerning the use of chemotherapy for EBC....